$10.6M grant supports innovative autism project
A new project at The Neuro, McGill University and the Research Institute of the McGill University Health Centre (RI-MUHC) has been awarded $10.6M in financial support as part of the Canada Foundation for Innovation’s (CFI) Innovation Fund.
Meet the 3MT|MT180 finalists!
Clinical Workshop
April 3, 2024, 3:00pm to 5:00 pm
Who can best present their research and make it resonate for a live audience, all in three minutes and with a single slide?
The 2024 Scaringi Lecture Series in Speech Language Pathology: Workshop
Clinical Workshop
April 4, 2024, 9:00 am to 4:00 pm
Room TBA
Using Narratives to Enhance Speech, Language and Communication in Students with Speech, Language and Communication Needs (SLCN): the magic of storytelling.
The 2024 Scaringi Lecture Series in Speech Language Pathology
McGill’s School of Communication Sciences and Disorders
is proud to be hosting a research talk on enhancing the language of adolescents
with DLD and a workshop on using narratives in clinical assessment and
intervention.
These events are funded by the Scaringi Lecture Series grant. This year the events are also co-sponsored by the
FRQSC group on Cognitive plasticity and language acquisition.
The 2024 Dr. Donald G. Doehring Memorial Lecture
McGill’s School of Communication Sciences and Disorders
is proud to announce:
The 2024 Dr. Donald G. Doehring Memorial Lecture
March 11, 4:30 to 6 pm
Leacock 232
855 Sherbrooke St. W.
Dr. Sheila Blumstein
Brown University
Making AI a partner in neuroscientific discovery
February 4 | Planned electrical shutdown at Islamic Studies Library, Marvin Duchow Music Library, and Schulich Library
La version française suit
A neurological disease paradigm shift
One of the things that makes developing effective treatments for Parkinson’s disease so challenging is its complexity. While some forms are caused by genetics, others have environmental factors, and patients can show a wide range of symptoms of varying severity. Diagnosis of Parkinson’s is also currently made very late, after the disease may have been in the brain for a decade or more.